Good evening, everyone —
Our newest free weekly lecture is now live: Can a Weight-Loss Shot Treat Sleep Apnea? Tirzepatide and the New Era of OSA Treatment.
In December 2024, the FDA approved tirzepatide — the first medication ever approved for obstructive sleep apnea — for moderate-to-severe OSA in adults with obesity. This lecture explains what tirzepatide is, how dual GIP/GLP-1 activation produces 16–20% weight loss, what the SURMOUNT-OSA trials showed (AHI reductions of about 27–30 events per hour versus about 5–6 on placebo, and remission in about 43% of patients in the non-CPAP trial), who still needs CPAP, the side effects and boxed thyroid warning, and what to watch for on repeat sleep studies.
Read the lecture and take the 10-question quiz here:
https://mysleepscoring.com/weekly-lectures/tirzepatide/
As always, this is education only, not medical advice. Questions and discussion are welcome — what do you think about a drug treatment for sleep apnea, and how should it fit alongside CPAP?
Fateh Nofal RPSGT